Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Rubin

Showing results (41-50 of 460) with videos related to

Pageof 46
Sort By:
European Urology|November 14, 2015
Genomic Correlates to the Newly Proposed Grading Prognostic Groups for Prostate CancerMark A Rubin, Gabriele Girelli, Francesca Demichelis
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 1, 2009
TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomasRaquel Esgueva, Francesca Demichelis, Mark A Rubin
European Urology|January 14, 2014
The lethal clone in prostate cancer: redefining the indexChristopher E Barbieri, Francesca Demichelis, Mark A Rubin
Archives of Pathology & Laboratory Medicine|September 26, 2002
Differential expression of cytokeratins 8 and 20 distinguishes craniopharyngioma from rathke cleft cystWei Xin, Mark A Rubin, Paul E McKeever
Current Protocols in Human Genetics|April 23, 2008
Constructing tissue microarrays for research useMartina Storz Schweizer, Lela Schumacher, Mark A Rubin
Histopathology|January 4, 2012
Molecular genetics of prostate cancer: emerging appreciation of genetic complexityChristopher E Barbieri, Francesca Demichelis, Mark A Rubin
Cancer Cell|February 16, 2013
Molecular archeology: unearthing androgen-induced structural rearrangements in prostate cancer genomesFrancesca Demichelis, Levi A Garraway, Mark A Rubin
Current Opinion in Systems Biology|October 30, 2018
Non-coding genetic variation in cancerTawny N Cuykendall, Mark A Rubin, Ekta Khurana
Oncogene|January 9, 2021
Loss and revival of androgen receptor signaling in advanced prostate cancerNicolò Formaggio, Mark A Rubin, Jean-Philippe Theurillat
Cell Cycle (Georgetown, Tex.)|August 25, 2012
Oncogenic transcription factors as master regulators of chromatin topology: a new role for ERG in prostate cancerOlivier Elemento, Mark A Rubin, David S Rickman
Pageof 46

Showing results (41-50 of 460) with videos related to

Sort By:
Pageof 46
European Urology|November 14, 2015
Genomic Correlates to the Newly Proposed Grading Prognostic Groups for Prostate CancerMark A Rubin, Gabriele Girelli, Francesca Demichelis
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 1, 2009
TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomasRaquel Esgueva, Francesca Demichelis, Mark A Rubin
European Urology|January 14, 2014
The lethal clone in prostate cancer: redefining the indexChristopher E Barbieri, Francesca Demichelis, Mark A Rubin
Archives of Pathology & Laboratory Medicine|September 26, 2002
Differential expression of cytokeratins 8 and 20 distinguishes craniopharyngioma from rathke cleft cystWei Xin, Mark A Rubin, Paul E McKeever
Current Protocols in Human Genetics|April 23, 2008
Constructing tissue microarrays for research useMartina Storz Schweizer, Lela Schumacher, Mark A Rubin
Histopathology|January 4, 2012
Molecular genetics of prostate cancer: emerging appreciation of genetic complexityChristopher E Barbieri, Francesca Demichelis, Mark A Rubin
Cancer Cell|February 16, 2013
Molecular archeology: unearthing androgen-induced structural rearrangements in prostate cancer genomesFrancesca Demichelis, Levi A Garraway, Mark A Rubin
Current Opinion in Systems Biology|October 30, 2018
Non-coding genetic variation in cancerTawny N Cuykendall, Mark A Rubin, Ekta Khurana
Oncogene|January 9, 2021
Loss and revival of androgen receptor signaling in advanced prostate cancerNicolò Formaggio, Mark A Rubin, Jean-Philippe Theurillat
Cell Cycle (Georgetown, Tex.)|August 25, 2012
Oncogenic transcription factors as master regulators of chromatin topology: a new role for ERG in prostate cancerOlivier Elemento, Mark A Rubin, David S Rickman
Pageof 46